The CDC released some changes to the recommended immunization schedule in early February of 2016. Here’s what you need to know:
Meningococcal B Disease
The Meningococcal B vaccine was approved by the Food and Drug administration in 2014. This was in response to outbreaks in colleges around the U.S. Meningococcal B (a cause of Menigitis) is a very rare disease, but when caught can be life-threatening. In fact, about 10-15 out of 100 people who catch Men B are killed, and many survivors will develop disabilities. The introduction of the vaccine has helped reduce cases.
The CDC’s immune schedule CDC’s immunization schedule is now suggesting the Men B vaccine at age 16 years with a booster one month later. Menactra (which protects against other strains of the meningococcal bacteria) is still recommended at age 11-12 years with a booster at age 16 years.
For more information on all vaccines, visit http://www.immunize.org/vis/